Search clinical trials for: Denufosol+tetrasodium+%28INS37217%29

Total 15 results

Merck Sharp & Dohme LLC

Withdrawn

A Study of Denufosol Tetrasodium Intravitreal Injection in Subjects With Post Cataract Extraction Macular Edema

Macular Edema, Cystoid
Merck Sharp & Dohme LLC

Terminated

Study to Treat Uveitis Associated Macular Edema

Uveitis | Cystoid Macular Edema
Merck Sharp & Dohme LLC

Completed

A Study in Subjects With Retinal Detachment

Retinal Detachment
Merck Sharp & Dohme LLC

Terminated

Study of Denufosol (INS37217) in Subjects With Rhegmatogenous Retinal Detachment

Retinal Detachment

United States
Merck Sharp & Dohme LLC

Completed

A Pharmacokinetic Evaluation Study in Healthy Volunteers

Healthy
Merck Sharp & Dohme LLC

Completed

A Pharmacokinetic Evaluation Study in Healthy Volunteers

Healthy
Merck Sharp & Dohme LLC
Cystic Fibrosis Foundation

Completed

Study of INS37217 Inhalation Solution in Mild to Moderate Cystic Fibrosis Lung Disease

Cystic Fibrosis
Merck Sharp & Dohme LLC

Completed

Study of Denufosol Tetrasodium in Patients With Cystic Fibrosis Lung Disease

Cystic Fibrosis
Merck Sharp & Dohme LLC

Completed

A Study in Pediatric Patients With Cystic Fibrosis Lung Disease

Cystic Fibrosis

United States
Merck Sharp & Dohme LLC

Completed

A Study in Adult and Pediatric Patients With Cystic Fibrosis

Cystic Fibrosis
Merck Sharp & Dohme LLC

Terminated

Study of Denufosol Inhalation Solution in Patients With Mild to Moderate Cystic Fibrosis Lung Disease

Cystic Fibrosis
Merck Sharp & Dohme LLC

Completed

Study of Denufosol Tetrasodium Inhalation Solution in Patients With Cystic Fibrosis (CF) Lung Disease

Cystic Fibrosis

United States, Australia, Canada, New Zealand
Merck Sharp & Dohme LLC

Completed

Study of Denufosol Inhalation Solution in Patients With Mild Cystic Fibrosis Lung Disease

Cystic Fibrosis
Merck Sharp & Dohme LLC

Terminated

Study 08-114 Open-label Extension of Study 08-110 - A Multi-Center Study of Denufosol Tetrasodium Inhalation Solution in Patients With Cystic Fibrosis Lung Disease (P08642) (DEFY)

Cystic Fibrosis
Merck Sharp & Dohme LLC

Completed

A Safety and Tolerability Study of Denufosol in 2-4 Year Olds (REACH-1)

Cystic Fibrosis

3

Subscribe